Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Subst Abuse Treat. 2003 Jun;24(4):291-7.

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

Author information

  • 1National Development and Research Institutes, Inc., 71 West 23 Street, 8th floor, 10010, New York, NY, USA. strauss@ndri.org

Abstract

Drug treatment programs are sites of opportunity for the delivery of hepatitis C (HCV) prevention and care services to drug users. Using data collected from a random nationwide sample (N = 595) of drug treatment programs in the United States, this study compares the provision of HCV services by drug-free and methadone maintenance treatment programs (MMTPs). It then examines and compares perceived inadequacies in this service provision from the perspective of the managers in these two types of programs. Findings indicate that MMTPs are providing more HCV services to their patients, and that a greater proportion of MMTPs are dissatisfied with their current level of HCV service provision. Managers of drug-free programs would like to be offering patients more HCV education, while MMTP managers would like to be providing more HCV testing to their patients, and more support and care for patients who are HCV+.

PMID:
12867202
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk